Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide, with genetic mutations playing a significant role in tumor progression and overall survival. This study investigates the impact of mutations in APC, KRAS, BRAF, and RNF43 on survival time using the analysis of patient data sourced from Cercek et al. 1 through cBioPortal. The results revealed that APC mutations were positively correlated with survival time, while KRAS, BRAF, and RNF43 were negatively correlated with survival time. These findings are consistent with previous literature and the roles of these genes in tumorigenesis and cancer progression. Further research on the importance of genetic mutations and prognostic biomarkers can improve targeted therapies and personalized treatments for colorectal cancer patients.
Aarohi Usapkar (Wed,) studied this question.